Join to View Full Profile
1500 East Medical Center Dr3rd Floor Taubman Center Recp DAnn Arbor, MI 48109
Phone+1 734-936-5899
Fax+1 734-615-2156
Dr. Miceli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Corewell Health (Dearborn)Residency, Internal Medicine, 2009 - 2012
University of New Mexico School of MedicineFellowship, Infectious Disease, 2007 - 2009
University of Buenos AiresClass of 1992
Certifications & Licensure
MI State Medical License 2009 - 2025
NM State Medical License 2007 - 2009
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- Blastomycosis.Shiwei Zhou, Carol A Kauffman, Marisa H Miceli
Infectious Disease Clinics of North America. 2025-03-01 - Coccidiomycosis septic arthritis presenting as ankle monoarthritis in a patient with presumed psoriatic arthritis.Stephanie Tancer, Adam Ressler, Marisa H Miceli, Beth I Wallace
BMJ Case Reports. 2024-09-17 - Evaluation of Turnaround Times for Antigen Testing in Hospitalized Patients With Histoplasmosis and Blastomycosis.Liam M Dalton, Carol A Kauffman, Blair Richards, Marisa H Miceli
Open Forum Infectious Diseases. 2024-09-01
Press Mentions
Compassionate Use Patient Treated with Matinas BioPharma’s MAT2203 and Showing Complete Clinical Resolution of Rare R. Mucilaginosa Fungal Infection Featured in Oral Presentation at ECCMIDApril 18th, 2023- Patient with Candida Krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical ResolutionOctober 12th, 2023
- Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical ResponseMarch 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
